Shingrix Prefilled Syringe Gets FDA Greenlight, According to GSK
July 17, 2025

The prefilled syringe presentation streamlines administration of the vaccine, eliminating the need to combine the lyophylized antigen and separate adjuvant.

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill
July 17, 2025

Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.

Digital Latency Measures Refine Early Detection of Cognitive Decline: Expert Review of Evidence
July 17, 2025

Digital latency measures enhance early detection of cognitive decline, revealing neurodegenerative changes before traditional tests indicate impairment.

Treatment of Neuropathic Pain: A Close Look at a New Meta-Analysis
July 17, 2025

For the often treatment-resistant pain of neuropathic conditions, the meta-analysis includes updated evidence for both pharmacologic and neuromodulatory interventions.

Otsuka and Lundbeck Will Face Scrutiny Over Investigational PTSD Therapy at July 18 FDA AdComm Meeting
July 17, 2025

FDA's Psychopharmacologic Drugs Advisory Committee will evaluate the novel brexpiprazole/sertraline combination, weighing efficacy against existing therapies amid mixed trial results.

Pre- and Post-Menopausal Hormone Therapy Has Differential Effect on Breast Cancer Subtypes
July 17, 2025

Combined estrogen-progestin hormone therapy used to manage VMS of menopause was associated with a higher risk of developing luminal-like breast cancer subtypes and other subtypes.

Physicians Alarmed by Fad Diets on Social Media: Daily Dose
July 17, 2025

Your daily dose of the clinical news you may have missed.

Monu Khanna, MD, on Why Cardiometabolic Screening Must Start Early in Patients with Obesity
July 16, 2025

Dr Khanna urges early screening for cardiometabolic risk in patients with obesity and highlights the role of primary care in prevention and education.

Lifestyle Medicine Is at a Tipping Point in the US, Expert Says, and It Could Be Just in Time
July 16, 2025

Without a shift in the approach to disease prevention and management in the US, the health system won't be able to handle the burden of our morbidity, says Richard Rosenfeld, MD, MPH, MBA.

Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds
July 16, 2025

ENDO 2025. People with inconsistent access to GLP-1 medications still achieved clinically significant weight loss when therapy was combined with lifestyle changes and coaching.